Advertisement

Magnetic Resonance-Guided Embolization of Low-Flow Vascular Malformations

  • Sumera Ali
  • Clifford R. Weiss
  • Daniel P. Hsu
  • Jonathan S. Lewin
Part of the Medical Radiology book series (MEDRAD)

Abstract

Low-flow vascular malformations are congenital, benign lesions that affect both children and adults. They occur as a result of errors during the embryological development of the vessels and can present at any time during life with pain, disfigurement, functional impairment and bleeding. Currently, the mainstay of treatment is sclerotherapy, which is performed by interventional radiologists using ultrasound and X-ray angiography guidance to treat the lesions. Although very effective, it has certain limitations such as deep and scarred lesions (which often occur due to multiple treatments) that are difficult to access using ultrasound. Moreover, patients with vascular malformations (many of whom are children) are repeatedly exposed to ionizing radiation as these lesion typically require multiple treatment sessions. Sclerotherapy using MR guidance is a relatively new technique and has shown to be safe and effective in several pilot studies. Lesions can be easily identified on T2-weighted, fat-saturated MR imaging, regardless of lesion depth and overlying scar tissue. Furthermore, the multiplanar capabilities of MR allow for accurate, real-time needle targeting with simultaneous visualization of surrounding critical structures, all without the use of ionizing radiation. In this chapter, we have reviewed the current literature and shared our own experience in treating the low-flow vascular malformations using MR guidance.

Keywords

Vascular Malformation Venous Malformation Lymphatic Malformation Ethanolamine Oleate Sodium Tetradecyl Sulfate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Andreisek G, Nanz D, Weishaupt D, Pfammatter T (2009) MR imaging-guided percutaneous sclerotherapy of peripheral venous malformations with a clinical 1.5-T unit: a pilot study. J Vasc Interv Radiol 20:879–887PubMedCrossRefGoogle Scholar
  2. Baum S, Pentecost MJ (eds) (2006) Abrams’ angiography: interventional radiology, 2nd edn. Lippincott Williams and Wilkins, PhiladelphiaGoogle Scholar
  3. Berenguer B, Burrows PE, Zurakowski D, Mulliken JB (1999) Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 104:1–11; discussion 2–5Google Scholar
  4. Boll DT, Merkle EM, Lewin JS (2004) Low-flow vascular malformations: MR-guided percutaneous sclerotherapy in qualitative and quantitative assessment of therapy and outcome. Radiology 233:376–384PubMedCrossRefGoogle Scholar
  5. Boll DT, Merkle EM, Lewin JS (2005) MR-guided percutaneous sclerotherapy of low-flow vascular malformations in the head and neck. Magn Reson Imaging Clin N Am 13:595–600PubMedCrossRefGoogle Scholar
  6. Brouillard P, Vikkula M (2007) Genetic causes of vascular malformations. Hum Mol Genet 16 Spec No. 2:R140–R149Google Scholar
  7. Burrows PE, Mason KP (2004) Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 15:431–445PubMedCrossRefGoogle Scholar
  8. Chen EY, Hostikka SL, Oliaei S, Duke W, Schwartz SM, Perkins JA (2009) Similar histologic features and immunohistochemical staining in microcystic and macrocystic lymphatic malformations. Lymphat Res Biol 7:75–80PubMedCrossRefGoogle Scholar
  9. Cho K and Mitchell SE (2009) Congenital vascular anomalies: classification and terminology, 561–571Google Scholar
  10. Choi DJ, Alomari AI, Chaudry G, Orbach DB (2009) Neurointerventional management of low-flow vascular malformations of the head and neck. Neuroimaging Clin N Am 19:199–218PubMedCrossRefGoogle Scholar
  11. de Serres LM, Sie KC, Richardson MA (1995) Lymphatic malformations of the head and neck. A proposal for staging. Arch Otolaryngol Head Neck Surg 121:577–582PubMedCrossRefGoogle Scholar
  12. DiCamillo P, Gilson W, Flammang A, Pan L, Lewin JS, Weiss C (2012) MR-guided sclerotherapy of vascular and lymphatic malformations: our first year experiences. In: International society for magnetic resonance in medicine, Melbourne, AustraliaGoogle Scholar
  13. Dompmartin A, Acher A, Thibon P et al (2008) Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol 144:873–877PubMedCrossRefGoogle Scholar
  14. Donnelly LF, Adams DM, Bisset GS 3rd (2000) Vascular malformations and hemangiomas: a practical approach in a multidisciplinary clinic. AJR Am J Roentgenol 174:597–608PubMedGoogle Scholar
  15. Enjolras O, Wassef M, Chapot R (2007) Introduction: ISSVA classification, Color atlas of vascular tumors and vascular malformations, illustrated edn. Cambridge University Press, CambridgeGoogle Scholar
  16. Greene AK, Alomari AI (2011) Management of venous malformations. Clin Plast Surg 38:83–93PubMedCrossRefGoogle Scholar
  17. Gutierrez S, Mitchell S, Chen X, Becker D, Sepkuty J, Ritzl E (2011) Intraoperative neurophysiologic monitoring to prevent injuries to peripheral nervous structures during embolization procedures. In: International society for the study of vascular anomalies, BrusselsGoogle Scholar
  18. Hayashi N, Masumoto T, Okubo T et al (2003) Hemangiomas in the face and extremities: MR-guided sclerotherapy––optimization with monitoring of signal intensity changes in vivo. Radiology 226:567–572PubMedCrossRefGoogle Scholar
  19. Lewin JS, Merkle EM, Duerk JL, Tarr RW (1999) Low-flow vascular malformations in the head and neck: safety and feasibility of MR imaging-guided percutaneous sclerotherapy––preliminary experience with 14 procedures in three patients. Radiology 211:566–570PubMedGoogle Scholar
  20. Marler JJ, Mulliken JB (2005) Current management of hemangiomas and vascular malformations. Clin Plast Surg 32:99–116, ixGoogle Scholar
  21. Mulliken JB, Glowacki J (1982) Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69:412–422PubMedCrossRefGoogle Scholar
  22. Mulliken JB, Fishman SJ, Burrows PE (2000) Vascular anomalies. Curr Probl Surg 37:517–584PubMedCrossRefGoogle Scholar
  23. Nehra D, Jacobson L, Barnes P, Mallory B, Albanese CT, Sylvester KG (2008) Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children. J Pediatr Surg 43:451–460PubMedCrossRefGoogle Scholar
  24. Perkins JA, Manning SC, Tempero RM et al (2010) Lymphatic malformations: review of current treatment. Otolaryngol Head Neck Surg 142:795–803PubMedCrossRefGoogle Scholar
  25. Puig S, Casati B, Staudenherz A, Paya K (2005) Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy. Eur J Radiol 53:35–45PubMedCrossRefGoogle Scholar
  26. Renton JP, Smith RJ (2011) Current treatment paradigms in the management of lymphatic malformations. Laryngoscope 121:56–59PubMedCrossRefGoogle Scholar
  27. Smith RJ (2004) Lymphatic malformations. Lymphat Res Biol 2:25–31PubMedCrossRefGoogle Scholar
  28. Smith MC, Zimmerman MB, Burke DK, Bauman NM, Sato Y, Smith RJ (2009) Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope 119:107–115PubMedCrossRefGoogle Scholar
  29. Su L, Fan X, Zheng L, Zheng J (2010) Absolute ethanol sclerotherapy for venous malformations in the face and neck. J Oral Maxillofac Surg 68:1622–1627PubMedCrossRefGoogle Scholar
  30. Tekes A, Ali S, Sinha A, et al (2012) Comparison of MRI and dynamic contrast enhanced MRA/MRV, and percutaneous venogram in subclassification of venous malformations. In: SIR, San FranciscoGoogle Scholar
  31. Zhou Q, Zheng JW, Mai HM et al (2011) Treatment guidelines of lymphatic malformations of the head and neck. Oral Oncol 47:1105–1109PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Sumera Ali
    • 1
  • Clifford R. Weiss
    • 1
  • Daniel P. Hsu
    • 2
  • Jonathan S. Lewin
    • 1
  1. 1.Russell H. Morgan Department of Radiology and Radiological ScienceJohns Hopkins School of MedicineBaltimoreUSA
  2. 2.Division of Interventional NeuroradiologyUniversity Hospitals Case Medical CenterClevelandUSA

Personalised recommendations